About Faecal-Immunochemical-Test.co.uk

Faecal-immunochemical-test.co.uk is a website that is dedicated to raising awareness amongst Clinicians and Laboratories about the value of testing for faecal occult blood using the immunochemical turbidimetric method.

Alpha Laboratories

This website is published by Alpha Laboratories Limited, a specialist diagnostic company that has been a leader in faecal testing technology in the UK for over 20 years. As the market leader for guaiac-based faecal occult blood testing in hospital laboratories, Alpha Laboratories became involved with the national bowel cancer screening programmes, as they were introduced, winning tenders in all four UK countries. These initiatives assess the average risk in asymptomatic populations, aiming to detect bowel cancer at an early stage, when treatment is more likely to be effective.

Technology has now changed with the introduction of more specific and sensitive quantitative faecal immunochemical (FIT) testing that can be automated. FIT has been implemented across the UK for screening programmes and for symptomatic testing. Alpha Laboratories continues to provide quantitative FIT as the front line test in the Scottish, Welsh, Northern Irish Bowel Screening Programmes.

Alpha Laboratories’ experience can support clinicians and clinical scientists in establishing a FIT service, providing education, product demonstrations and logistics solutions.

You can read more about Alpha Laboratories here.

The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.

Visit the Alpha Laboratories Website

Alpha Laboratories is the UK partner and distributor for Minaris Medical Co., Ltd., previously known as Hitachi Chemical Diagnostics Systems Co., Ltd and Kyowa Medex Ltd. Specialising in in vitro diagnostics and medical devices, Minaris Medical is focused on R&D supported by revolutionary research and technology, and conduct their business activities with the management vision of “continued advancement while devoted to healthcare, providing new value to clinical testing, and upholding social responsibility”.